Billionaire investor Carl Icahn accused Forest Laboratories of using a licensing agreement to block takeovers and renewed his lobbying for other shareholders to vote for his board candidates at the company’s annual meeting next week.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
